Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas

By comparing the target proteins (TPs) of classic traditional Chinese medicine (TCM) herbal formulas and modern drugs used for treating coronary artery disease (CAD), this study aimed to identify potential therapeutic TPs for treating CAD. Based on the theory of TCM, the Xuefu-Zhuyu decoction (XZD) and Gualou-Xiebai-Banxia decoction (GXBD), both of which are classic herbal formulas, were selected for treating CAD. Data on the chemical ingredients and corresponding TPs of the herbs in these two formulas and data on modern drugs approved for treating CAD and related TPs were retrieved from professional TCM and bioinformatics databases. Based on the associations between the drugs or ingredients and their TPs, the TP networks of XZD, GXBD, and modern drugs approved for treating CAD were constructed separately and then integrated to create a complex master network in which the vertices represent the TPs and the edges, the ingredients or drugs that are linked to the TPs. The reliability of this master network was validated through statistical tests. The common TPs of the two herbal formulas have a higher possibility of being targeted by modern drugs in comparison with the formula-specific TPs. A total of 114 common XZD and GXBD TPs that are not yet the target of modern drugs used for treating CAD should be experimentally investigated as potential therapeutic targets for treating CAD. Among these TPs, the top 10 are NOS3, PTPN1, GABRA1, PRKACA, CDK2, MAOB, ESR1, ADH1C, ADH1B, and AKR1B1. The results of this study provide a valuable reference for further experimental investigations of therapeutic targets for CAD. The established method shows promise for searching for potential therapeutic TPs based on herbal formulas. It is crucial for this work to select beneficial therapeutic targets of TCM, typical TCM syndromes, and corresponding classic formulas.

[1]  V. M. Nisha,et al.  Insulin resistance by TNF-α is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARγ agonist , 2015, Molecular and Cellular Endocrinology.

[2]  Jin Gu,et al.  Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients , 2013, Scientific Reports.

[3]  G. Ji,et al.  Navigating Traditional Chinese Medicine Network Pharmacology and Computational Tools , 2013, Evidence-based complementary and alternative medicine : eCAM.

[4]  Kelvin Chan,et al.  Chinese medicinal materials and their interface with Western medical concepts. , 2005, Journal of ethnopharmacology.

[5]  P. Xiao,et al.  Network Pharmacology: A Rosetta Stone for Traditional Chinese Medicine , 2014, Drug development research.

[6]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[7]  D. Lawlor,et al.  Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. , 2013, European heart journal.

[8]  R. Lyman Ott.,et al.  An introduction to statistical methods and data analysis , 1977 .

[9]  Wen-yue Jiang,et al.  Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. , 2005, Trends in pharmacological sciences.

[10]  M. Newman,et al.  The structure of scientific collaboration networks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Bo Zhang,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application: Traditional Chinese medicine network pharmacology: theory, methodology and application , 2014 .

[12]  Xinbing Wei,et al.  Hydroxysafflor Yellow A suppresses thrombin generation and inflammatory responses following focal cerebral ischemia-reperfusion in rats. , 2010, Bioorganic & medicinal chemistry letters.

[13]  M. Newman.  Coauthorship networks and patterns of scientific collaboration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Keji Chen,et al.  Clinical and Epidemiological Investigation of TCM Syndromes of Patients with Coronary Heart Disease in China , 2012, Evidence-based complementary and alternative medicine : eCAM.

[15]  Bao-yan Liu,et al.  Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. , 2012, Journal of ethnopharmacology.

[16]  R. Karas,et al.  Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. , 2008, The Journal of endocrinology.

[17]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[18]  F. Cheung.  TCM: Made in China , 2011, Nature.

[19]  Xiuping Chen,et al.  Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology , 2013, PloS one.

[20]  Bo Zhang,et al.  A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge-Gen-Qin-Lian Decoction for Treatment of Type 2 Diabetes , 2014, Evidence-based complementary and alternative medicine : eCAM.

[21]  E. Inscho,et al.  Protein tyrosine phosphatase 1B (PTP1B): a major regulator of leptin‐mediated control of cardiovascular function , 2009, Circulation.

[22]  T. Kaptchuk,et al.  A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction (血府逐瘀汤) on endothelial cells , 2012, Chinese Journal of Integrative Medicine.

[23]  Wei Zhou,et al.  A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery. , 2014, Journal of ethnopharmacology.

[24]  Hui-qin Luo,et al.  Traditional Chinese medicine for chronic fatigue syndrome: a systematic review of randomized clinical trials. , 2014, Complementary therapies in medicine.

[25]  N. Kaludercic,et al.  Monoamine oxidases as sources of oxidants in the heart. , 2014, Journal of molecular and cellular cardiology.

[26]  A. Santos,et al.  Anti-inflammatory action of hydroalcoholic extract, dichloromethane fraction and steroid α-spinasterol from Polygala sabulosa in LPS-induced peritonitis in mice. , 2014, Journal of ethnopharmacology.

[27]  P Manimaran,et al.  Prediction of conditional gene essentiality through graph theoretical analysis of genome-wide functional linkages. , 2009, Molecular bioSystems.

[28]  D. Rader.  New Therapies for Coronary Artery Disease: Genetics Provides a Blueprint , 2014, Science Translational Medicine.

[29]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[30]  Z. Boli.  Literature Analysis of Studies on the TCM Syndromes of Coronary Heart Disease in the Recent 40 Years , 2011 .

[31]  G. Maciocia.  The Practice of Chinese Medicine: The Treatment of Diseases with Acupuncture and Chinese Herbs , 1994 .

[32]  Mark E. J. Newman.  A measure of betweenness centrality based on random walks , 2005, Soc. Networks.

[33]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[34]  Hai-yan Zhu,et al.  Gualou xiebai banxia decoction inhibits NF-kappa B-dependent inflammation in myocardial ischemia-reperfusion injury in rats. , 2011, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[35]  N. Chang,et al.  Traditional Chinese medicine, Xue-Fu-Zhu-Yu decoction, potentiates tissue plasminogen activator against thromboembolic stroke in rats. , 2011, Journal of ethnopharmacology.

[36]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[37]  Thomas Scherngell,et al.  Is the United States Still Dominant in the Global Pharmaceutical Innovation Network? , 2013, PloS one.

[38]  Bo Zhang,et al.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.

[39]  F. Sellke,et al.  Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens , 2014, Cell cycle.

[40]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[41]  A. Levinson.  Cancer Therapy Reform , 2010, Science.

[42]  W. Kummer,et al.  NOSIP, a novel modulator of endothelial nitric oxide synthase activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  N. Opitz,et al.  NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[45]  A. Bhatnagar,et al.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts. , 2009, Chemico-biological interactions.

[46]  Yuanjia Hu,et al.  An Analysis of Chemical Ingredients Network of Chinese Herbal Formulae for the Treatment of Coronary Heart Disease , 2015, PloS one.

[47]  S. Pan,et al.  New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development , 2011, Evidence-based complementary and alternative medicine : eCAM.

[48]  M. Newman.  1 Who is the best connected scientist ? A study of scientific coauthorship networks , 2004 .

[49]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[50]  Junsong Wang,et al.  ¹H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet. , 2013, Journal of pharmaceutical and biomedical analysis.

[51]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[52]  N. Kokudo,et al.  Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection. , 2013, Drug discoveries & therapeutics.

[53]  Gui-biao Zhang,et al.  Network Pharmacology: A New Approach for Chinese Herbal Medicine Research , 2013, Evidence-based complementary and alternative medicine : eCAM.

[54]  F. Lozano.  Basic Theories of Traditional Chinese Medicine , 2014 .

[55]  M. Levandowsky,et al.  Distance between Sets , 1971, Nature.

[56]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[57]  Xiaojie Xu,et al.  Potential synergism and inhibitors to multiple target enzymes of Xuefu Zhuyu Decoction in cardiac disease therapeutics: a computational approach. , 2007, Bioorganic & medicinal chemistry letters.

[58]  Emanuel F. Petricoin,et al.  Network-targeted combination therapy : a new concept in cancer treatment , 2004 .

[59]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[60]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[61]  A. Hopkins.  Network pharmacology , 2007, Nature Biotechnology.

[62]  W. Xie,et al.  Novel effects of macrostemonoside A, a compound from Allium macrostemon Bung, on hyperglycemia, hyperlipidemia, and visceral obesity in high-fat diet-fed C57BL/6 mice. , 2008, European journal of pharmacology.

[63]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[64]  M. Baba,et al.  Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development , 2004, Cancer science.

[65]  J. Zhi,et al.  The effects of hydroxysafflor yellow A on blood pressure and cardiac function. , 2012, Journal of ethnopharmacology.

[66]  Hua Zhou,et al.  Macrostemonoside A promotes visfatin expression in 3T3-L1 cells. , 2007, Biological & pharmaceutical bulletin.

[67]  A. Fliri,et al.  Cause-effect relationships in medicine: a protein network perspective. , 2010, Trends in pharmacological sciences.

[68]  U. Brandes.  A faster algorithm for betweenness centrality , 2001 .

[69]  Mathieu Bastian,et al.  Gephi: An Open Source Software for Exploring and Manipulating Networks , 2009, ICWSM.

[70]  Lei Wu,et al.  Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease , 2015, Evidence-based complementary and alternative medicine : eCAM.

[71]  Jiang Wu,et al.  Advances in Studies on Pharmacological Functions of Ligustilide and their Mechanisms , 2012 .